Dr. Dino PratoEnvita Medical Centers · Founder and CEO at Envita Medical Centers

The biggest barrier to cancer care isnt always science its the system #shorts

21 Jan 2026 · 1 min

Watch on YouTube

0:50

In this short monologue, the speaker argues that the healthcare system—particularly regulatory frameworks like the FDA—has become the primary obstacle to delivering personalized cancer treatments that could extend lives. Emphasizing that cancer is a highly individual disease, they advocate for precision oncology that moves beyond one‑size‑fits‑all standards. By leveraging better testing, biomarkers, and data, clinicians can custom‑design treatment plans that combine the best of conventional medicine, integrative approaches, and immunotherapy. The speaker calls for an adaptive FDA that recognizes and approves such individualized regimens, positioning this moment as a historic opportunity to transform cancer care.

Chapters

What if the system designed to protect you and me is now the single biggest bottleneck to slowing down personalized treatments that could help people live longer and fight cancer better? Cancer is a personal war and the targets need precision and it's important that we seek after a model that helps people get the individual care they need. It's about time. We need precision oncology not a one size fits all and we need to respect the biology of everybody's different unique presentation of their chronic disease so we can help them heal. We don't have to fall into one size fits all standard of care. We can open that up with better testing and better targeting and that's been my life's work and that's why I'm so excited because we're in a special time in history where we can get the best of conventional the best of integrative the best of immunotherapy. If we have the markers and the data we can custom build that. Imagine an FDA that recognizes that.